DSM-Firmenich Venturing and Fonterra are both founding investors.
Vivici (the Netherlands), the new joint venture of DSM (Kaiseraugst, Switzerland) and Fonterra (Auckland, New Zealand) that uses precision fermentation to create animal-free dairy protein ingredients, announced it successfully closed its seed funding round. DSM-Firmenich Venturing and Fonterra are both founding investors.
With DSM and Fonterra as its founding companies, Vivici “leverages decades of experience in developing and scaling bioprocesses and holds world-leading knowledge in the isolation and application of dairy proteins,” the Vivici website states. It also has “world-class expertise in strain development, bioprocess engineering, and market approval.”
“Vivici is an exciting opportunity to combine DSM-Firmenich’s world-leading precision fermentation expertise with Fonterra’s world-leading dairy science and technology,” stated Komal Mistry-Mehta, chief innovation and brand officer at Fonterra, in a press release. Of Fonterra, Mistry-Mehta said, “This partnership aligns well with the co-op’s strategy to be a leader in dairy innovation and science.”
Pieter Wolters, managing director of DSM-Firmenich Venturing, added that Vivici “builds on multiple years of joint technology and application development, and is now well-positioned as an agile startup company.”